White House deputy counsel Makan Delrahim will bring decades of policy and lobbying experience to the U.S. Department of Justice as the president's pick to lead the Antitrust Division, a move experts say likely heralds a return to a traditional Republican enforcement approach.
Even with billions of dollars at stake, pharmaceutical companies are surprisingly slow to prepare for the competitive onslaught brought by generic drugs, a new study concludes.
A judge has denied Netflix’ request to dismiss claims by rival Blockbuster that it is trying to monopolize the online movie rental market by using unenforceable patents.
Recently hit with another U.S. antitrust lawsuit, Finnish metal firm Outokumpu Oyj has vowed to fight the slew of litigation accusing the firm of engaging in anti-competitive practices in the copper pipe market.
Rambus Inc. has been granted a conditional stay in the final round of its patent infringement lawsuit with Hynix Semiconductor Inc. due to a pending antitrust case brought against Rambus by the Federal Trade Commission.
Five of Brazil’s top orange juice exporters have agreed to pay $46.7 million to end a government investigation into whether the companies acted as a cartel.
Siding with German regulators, the European Commission has ordered telecommunications operator Deutsche Telekom AG to make its new ultrahigh-speed broadband network accessible to competitors.
Still trying to fend off allegations of anti-competitive behavior over Ditropan XL, Johnson & Johnson subsidiary Alza Corporation has hit Mylan Laboratories Inc. with another patent infringement lawsuit involving the blockbuster bladder control drug.
Temporarily throwing in the towel, Microsoft Corp. has announced that it will launch two Korean versions of its Windows operating system in order to comply with a looming deadline set by the country’s antitrust regulator.
Although the U.S. Supreme Court has denied Stolt-Nielsen SA’s application for an injunction against government prosecution, the transport company has received support in its fight for amnesty from an unexpected source: the government of Luxembourg.
Federal Trade Commission Chairman Deborah Platt Majoras voiced her opinion in the increasingly heated debate on net neutrality on Monday, questioning the usefulness of government regulation.
Federal prosecutors are seeking more information about South Carolina’s decision to greenlight a Tenet Healthcare Corp.-owned county hospital’s expansion rather than allowing competing, out-of-state health care operators to enter the market.
In a slap in the face to Stolt-Nielsen SA, the U.S. Supreme Court on Monday turned down an application that would have preserved an injunction barring government prosecutors from bringing charges against the Norwegian shipping company.
The unsecured creditors committee of bankrupt Collins & Aikman Corp. wants to investigate DaimlerChrysler Corp., Ford Motor Corp. and General Motors Corp.—the auto supplier’s largest customers—for alleged violations of antitrust law.
The merger of two natural gas storage companies has been thrown into jeopardy, after the U.S. Federal Trade Commission challenged the deal on the grounds that the transaction would result in higher prices for consumers.
Attorneys spent a second day in court Monday arguing over whether Apotex’ generic version of the blockbuster blood thinner Plavix should be allowed on the market.
As the Office of Fair Trading begins its study of the British airports market, Virgin Atlantic is expected to recommend that the watchdog launch a Competition Commission inquiry into embattled airports group BAA Plc.
Moving to bolster its ranks, the U.S. Department of Justice’s Antitrust Division said Friday it has appointed noted economist Dennis W. Carlton to serve as the department’s deputy assistant attorney general for economic analysis.
Citing fears that the new draft of China’s anti-monopoly law could be used to target foreign firms, the American Chamber of Commerce on Friday called for Beijing to ensure that the law’s enforcement body will be independent and free of bias.
Class action suits are popping up, following the U.S. Federal Trade Commission’s decision that technology-licensing company Rambus Inc. violated antitrust laws and deceived a group responsible for establishing industry-wide standards for memory-chip equipment.
Canadian generic drug maker Apotex has accused Bristol-Myers of engaging in illegal secret side deals that led to a Department of Justice investigation into a Plavix settlement agreement.